Skip to main content

Table 3 Liver enzymes and function

From: Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study

A

Anidulafungin

Micafungin

P

(n = 30)

(n = 33)

 Liver failurea

9 (30)

2 (6)

0.01

 Increased serum AST (U/L) after starta

13 (43)

12 (36)

0.58

 Increased serum ALT (U/L) after starta

13 (43)

10 (30)

0.29

 Serum AST (U/L) at start

95 (282)

55 (76)

0.09

 Serum ALT (U/L) at start

56 (125)

39 (59)

0.13

 Serum AST (U/L) at stop

115 (1011)

52 (108)

0.17

 Serum ALT (U/L) at stop

75 (312)

45 (68)

0.14

 Serum AST (U/L) peak

285 (228)

116 (181)

0.11

 Serum ALT (U/L) peak

150 (404)

70 (126)

0.15

 Serum bilirubin (μmol/L) peak

71 (192)

15 (29)

0.05

 Prothrombin Time (sec) peak

18.3 (15.4)

17.8 (8.0)

0.27

B

Anidulafungin

Micafungin

P

(n = 21)

(n = 31)

 Increased serum AST (U/L) after starta

8 (38)

11 (35)

0.85

 Increased serum ALT (U/L) after starta

7 (33)

9 (29)

0.74

 Serum AST (U/L) at start

61 (98)

55 (73)

0.82

 Serum ALT (U/L) at start

43 (75)

39 (54)

0.89

 Serum AST (U/L) at stop

44 (141)

49 (79)

0.98

 Serum ALT (U/L) at stop

41 (83)

45 (54)

0.99

 Serum AST (U/L) peak

129 (267)

113 (158)

0.88

 Serum ALT (U/L) peak

69 (209)

61 (119)

0.95

 Serum bilirubin (μmol/L) peak

20 (105)

14 (27)

0.74

 Prothrombin Time (sec) peak

16.6 (7.5)

17.8 (5.3)

0.68

  1. Numbers (percentage) aor median (interquartile range). Liver enzymes and function in all patients who were treated with anidulafungin and micafungin (A) and in patients without liver failure (B)
  2. Abbreviations: ALT alanine transaminase, AST aspartate transaminase